Manipulation of ER–mitochondria interactions with mitofusin modulators reduces cardiac damage during myocardial infarction in mice

Axelrod, Joshua L., Nichtová, Zuzana, Schneider, Timothy, Lee, Jaehoon, Pekson, Ryan, Qin, Dongze, Ghazi, Madeeha, Kumar, Vinay, Margulets, Victoria, Kirshenbaum, Lorrie A., Santulli, Gaetano, Csordás, György, Calvert, John W., Kitsis, Richard N.
Nature Cardiovascular Research · Springer Nature · 2026-11-01 · DOI: 10.1038/s44161-026-00903-6

Abstract

Mitofusin (MFN) 1 and MFN2 are large outer mitochondrial membrane GTPases. Dimerization of MFNs on adjacent mitochondria mediates mitochondrial fusion. MFN2, but not MFN1, also resides at the endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR) membrane, and dimerization of MFNs on ER/SR and mitochondria tethers the two organelles. Here we report that cell-permeable peptides that perturb MFN conformations regulate myocardial infarct size by impacting ER/SR–mitochondria interactions and Ca^2+ transfer independently of changes in mitochondrial fusion. MFN activators increase ER/SR–mitochondria proximity, promote ER/SR to mitochondria Ca^2+ transfer and exacerbate infarct size in mice, with effects dependent on MFN2, but not MFN1, and on mitochondrial calcium uniporter, which transports Ca^2+ into the mitochondrial matrix. Conversely, although ER/SR–mitochondria proximity is not affected, MFN inhibitors reduce mitochondrial Ca^2+ transfer and infarct size, even when their administration is delayed until reperfusion. These findings demonstrate the feasibility of acutely modulating ER/SR–mitochondria interactions and Ca^2+ dynamics and suggest that pharmacological MFN inhibition may provide a new therapeutic strategy to limit cardiac damage during reperfused myocardial infarction. Axelrod, Nichtová et al. show that acute pharmacological modulation of mitofusins regulates ER/SR–mitochondria calcium transfer and markedly influences myocardial infarct size in mice, independently of mitochondrial fusion. Notably, mitofusin inhibition limits cardiac injury, even when administered at reperfusion, highlighting a potential therapeutic strategy for myocardial infarction.

Read at publisher →

Similar articles